Whittier Trust CO Bio N Tech Se Transaction History

Whittier Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	SELL	$86.65 - $120.54 $173,300 - $241,080	-2,000 Reduced 97.47%	52 $5,000
Q1 2025 May 02, 2025	BUY	$91.06 - $126.88 $182,120 - $253,760	2,000 Added 3846.15%	2,052 $186,000
Q2 2023 Jul 24, 2023	SELL	$102.58 - $129.66 $8,719 - $11,021	-85 Reduced 62.04%	52 $5,000
Q1 2023 Apr 21, 2023	BUY	$122.57 - $153.67 $4,657 - $5,839	38 Added 38.38%	137 $17,000
Q4 2022 Jan 25, 2023	BUY	$118.43 - $186.05 $1,658 - $2,604	14 Added 16.47%	99 $0

Q1 2022 Apr 29, 2022	BUY	$126.25 - $231.85 $10,731 - $19,707	85 New	85 $14,000

318

43.6M

1.15M

1.36M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.